相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy
Seung-Woo Baek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Carcinoma In Situ of the Urinary Bladder: A Systematic Review of Current Knowledge Regarding Detection, Treatment, and Outcomes
Jose Daniel Subiela et al.
EUROPEAN UROLOGY FOCUS (2020)
Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?
Juan Carlos Pardo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway
Dandan Qiu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Identification of an immunotherapy-responsive molecular subtype of bladder cancer
Bic-Na Song et al.
EBIOMEDICINE (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
Chiara Casadei et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
The PDGF/PDGFR pathway as a drug target
Natalia Papadopoulos et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
Mengxue Yu et al.
CELL DEATH & DISEASE (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells
Akira Ooki et al.
CANCER RESEARCH (2018)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status
Ho Won Kang et al.
ONCOLOGY LETTERS (2017)
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw et al.
CANCER DISCOVERY (2017)
YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor
Yi Liu et al.
SCIENTIFIC REPORTS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer
Ying Wang et al.
GROWTH FACTORS (2016)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer
Se-Ra Lee et al.
CLINICAL CANCER RESEARCH (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis
Enrique Redondo-Gonzalez et al.
BIOMED RESEARCH INTERNATIONAL (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Expression Signature Defined by FOXM1-CCNB1 Activation Predicts Disease Recurrence in Non-Muscle-Invasive Bladder Cancer
Seon-Kyu Kim et al.
CLINICAL CANCER RESEARCH (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Bladder Cancer in 2010 How Far Have We Come?
Bruce L. Jacobs et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)